Rising Resistance, Long-Acting Solutions: A Pharmacology Update for STI and HIV Management
- Speaker:
- Audrey M. Stevenson, PhD, MPH, MSN, FNP-BC
- Duration:
- 2 Hours 25 Minutes
- Format:
- Audio and Video
- Copyright:
-
Jun 29, 2026
- Product Code:
- POS078993
- Media Type:
- Digital Seminar
Description
- Resistance is rising: Latest protocols for multidrug-resistant gonorrhea and Mycoplasma genitalium
- Implement injectables: Cabotegravir and twice-yearly lenacapavir to solve pill fatigue and modernize your PrEP practice
- Navigate the bicillin shortage, updated syphilis algorithms, and key guideline changes across chlamydia, gonorrhea, and PID
The clinical landscape for infectious diseases is moving faster than ever, and clinicians are experiencing a pivotal shift in how HIV and STIs are managed. This presentation isn't just a refresher; it’s a high-impact roadmap to mastering long-acting therapies. You will learn how to select and prescribe medications for STIs, confidently provide PrEP, and understand strategies for transitioning patients to new therapeutic options.
Gain the ability to implement the latest twice-yearly injectables, address drug shortages using imported alternatives, and apply new pharmacological approaches to combat "pill fatigue." You’ll be prepared to go beyond standard protocols, using targeted pharmacotherapy strategies.
Credit
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
For a more detailed outline that includes times or durations of time, if needed, please contact cepesi@pesi.com.
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Access for Self-Study Program (Non-Interactive)
You will have access to this product for 12 months from the date of purchase.
Objectives
- Explain the benefits and implementation of Pre-exposure Prophylaxis (PrEP), including daily oral and long-acting injectable options like lenacapavir.
- Analyze the current staging aligned treatments for syphilis.
- Manage emerging antimicrobial-resistant gonococcal (AR GC) infections with the newest diagnostic and sequential therapy protocols.
Outline
The STI Toolbelt: Modern Diagnostics and Treatment Mastery
- Syphilis: Staging aligned treatments, reporting req, MMWR report on lab testing for syphilis, serologic algorithms, prevent false-positive trap, bicillin shortage/alternatives
- Gonorrhea: Ceftriaxone tx option, antibiotic resistances, test of cure after tx, current clinical trials
- Mycoplasma genitalium: Resistant STI in urethritis and cervicitis cases, macrolide resistance markers, NAATs - when to order, tx algorithm, macrolide resistance testing
- Chlamydia, trichomoniasis, and PID: Prescribing guideline updates
- BV: STI or not, management
- Other less common STIs: how to recognize and treat
Expedited Partner Therapy
- Who qualifies
- Does it work
Screening and Diagnostic Advances
- Opt-out screening
- Extra-genital testing
- Express visits, telehealth, and self-screening
HIV Prevention Pharmacology in the STI Era
- Universal screening standards
- PrEP modalities and regimens
- Clinical Pearls for long-acting injectables
- HIV management: The "U=U" standard
- Oral PrEP changes, injectable CAB, lenacapavir every 6 months
Target Audience
- Physicians
- Physician Assistants
- Nurses
- Nurse Practitioners
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...